Top compounds associated with response to POTEE


Feature Type Standardized
Nominal ANOVA
mRNA ABT-263 CTRPv2 pan-cancer AAC -0.086 0.02
mRNA BRD-K66453893 CTRPv2 pan-cancer AAC 0.076 0.02
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.076 0.02
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.086 0.02
mRNA staurosporine CTRPv2 pan-cancer AAC 0.17 0.02
mRNA dinaciclib CTRPv2 pan-cancer AAC 0.11 0.02
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.077 0.03
mRNA 968 CTRPv2 pan-cancer AAC 0.16 0.03
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.08 0.03
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.077 0.03
Download CSV